Inogen
INGN
271 hedge funds and large institutions have $2.92B invested in Inogen in 2018 Q4 according to their latest regulatory filings, with 73 funds opening new positions, 92 increasing their positions, 85 reducing their positions, and 81 closing their positions.
11% more call options, than puts
Call options by funds: $22.4M | Put options by funds: $20.2M
9.08% more ownership
Funds ownership: 100.54% → 109.62% (+9.1%)
8% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 85
10% less first-time investments, than exits
New positions opened: 73 | Existing positions closed: 81
4% less funds holding
Funds holding: 281 → 271 (-10)
44% less capital invested
Capital invested by funds: $5.24B → $2.92B (-$2.32B)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$208M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$106M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$63.1M |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$42M |
| 5 |
FAM
Fred Alger Management
New York
|
+$31.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$56.3M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$45.3M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$35.1M |
| 4 |
Morgan Stanley
New York
|
-$34.1M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$34.1M |
INGN Hedge Fund Activity: Q4 2018 in Review
271 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q4 2018, worth a combined $2.92B — down 44% from $5.24B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of INGN and 73 opened new positions — a net loss of 8 holders — while 85 trimmed existing stakes and 92 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $208M. The largest seller was Invesco, cutting an estimated $56.3M.
- 271 institutional investors held Inogen (INGN) as of Q4 2018, down from 281 in Q3 2018.
- Funds reported $2.92B of Inogen stock for Q4 2018, down 44% quarter-over-quarter.
- 73 funds opened new Inogen positions in Q4 2018 and 81 closed out, a net change of -8 holders.
- The largest Inogen buyer in Q4 2018 was Point72 Asset Management, an estimated $208M added.
- The largest Inogen seller in Q4 2018 was Invesco, an estimated $56.3M sold.
Based on aggregated 13F filings for Q4 2018.